Bipolar II
Resources for Patients and Caregivers
A type of bipolar disorder characterized by depressive and hypomanic episodes.
It involves at least one depressive episode lasting at least two weeks and at least one hypomanic episode lasting at least four days.
Depressive symptoms include sadness or hopelessness. Hypomanic symptoms include a persistently elevated or irritable mood.
Treatment includes counseling and medications, such as mood stabilizers.
Cluster Number:
Wiki Number: 09-Bipolar II
Diagnosis: One or more long sessions of depression, some hypo(lower)mania, but no full manic session
US Patients:
World Patients:
Sex Ratio:
Age Onset:
Brain Area:
Symptoms: May be more chronic and recurring in the depressive phase than Bipolar I.
Progression: May be a high risk of suicide. 25-50% of Bipolar II patients make at least one suicide attempt.
Causes:
Medications: Can be modified by several medications.
Therapies:
Youtube Video: Bipolar 1 or Bipolar 2 Disorder – Which is Worse?
Amazon or Library Book: Bipolar II Disorder Workbook
Click the book to link or order from Amazon.
Support Group: dsballiance.org; 800-326-3632
(Depression and Bipolar Support Alliance)
Contact your local Social Security office for possible Disability Benefits through their Disability Determination Services,
Section 12.04.
Resources for Physicians, Counselors and Researchers
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- A novel MSN-II feature extracted from T1-weighted MRI for discriminating between BD patients and MDD patientsby Kai Sun on November 18, 2024
CONCLUSIONS: Incorporating the high-level MSN_II based on radiomics features can improve the classification performance compared to models solely relying on GMV features alone. This result implied the potential application of the proposed high level MSN method and radiomics textural features on the MDD and BD clinical studies.
- Satisfactory Levels of Functionality and Quality of Life in Caregivers of Patients with Bipolar Disorder: Is this Possible?by Mariana Troesch on November 16, 2024
CONCLUSION: The results obtained indicate less functional impairment and a better perception of QoL when compared to literature data, demonstrating that there is a subgroup of caregivers who perform their caregiving role without significant compromise in these health aspects. Exploring other factors associated with functionality and QoL, such as resilience, the presence of psychological support, or others, may allow for better targeting of public health interventions, optimizing comprehensive...
- Associations between lifetime reproductive events among postmenopausal women with bipolar disorderby Katherine Gordon-Smith on November 13, 2024
CONCLUSIONS: Our findings suggest that women with BD with a history of premenstrual symptoms and postpartum depression are potentially at increased risk of experiencing episodes of depression in relation to the perimenopause. There are clinical and self-management implications in identifying a subgroup of women with BD who may be particularly vulnerable to episodes of mood disturbance during reproductive events.
- Who and how to screen for endogenous hypercortisolism in patients with mood disordersby Emanuele Ferrante on November 12, 2024
A strict association exists between mood disorders and endogenous hypercortisolism, namely Cushing's syndrome (CS). Indeed, CS is characterized by a wide range of mood disorders, such as major depression, generalized anxiety, panic disorders, bipolar disorders up to psychosis, with major depression being the most frequent, with a prevalence of 50-80%, and potentially representing the clinical onset of disease. Despite this observation, the exact prevalence of hypercortisolism in patients with...